Amgen will spend $13.4 billion to acquire Celgene's blockbuster drug, Otezla, — helping settle Federal Trade Commission concerns facing Bristol-Myers Squibb's acquisition of Celgene.

source https://finance.yahoo.com/m/2f7b8916-3fca-3083-897f-c82377398eb9/why-amgen%26%2339%3Bs-%2413.4-billion.html?.tsrc=rss